APLS - Apellis Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

APLS is currently covered by 20 analysts with an average price target of $33.42. This is a potential upside of $13.95 (71.65%) from yesterday's end of day stock price of $19.47.

Apellis Pharmaceuticals's activity chart (see below) currently has 223 price targets and 286 ratings on display. The stock rating distribution of APLS is 62.84% BUY and 37.16% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 62.85% with an average time for these price targets to be met of 186.32 days.

Highest price target for APLS is $82, Lowest price target is $18, average price target is $42.16.

Most recent stock forecast was given by TAZEEN AHMAD from BAML on 16-Jul-2025. First documented stock forecast 04-Dec-2017.

Currently out of the existing stock ratings of APLS, 93 are a BUY (62.84%), 55 are a HOLD (37.16%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$24

$4.53 (23.27%)

$23

4 days ago
(16-Jul-2025)

3/10 (30%)

$4.25 (21.52%)

12

Hold

$29

$9.53 (48.95%)

$26

1 months 18 days ago
(02-Jun-2025)

8/13 (61.54%)

$9.86 (51.52%)

111

Buy

$41

$21.53 (110.58%)

$51

1 months 28 days ago
(22-May-2025)

20/25 (80%)

$23.22 (130.60%)

216

Hold

$20

$0.53 (2.72%)

$30

2 months 6 days ago
(14-May-2025)

5/11 (45.45%)

$3.3 (19.76%)

60

Buy

$52

$32.53 (167.08%)

$106

2 months 11 days ago
(09-May-2025)

2/17 (11.76%)

$34.7 (200.58%)

570

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is APLS (Apellis Pharmaceuticals) average time for price targets to be met?

On average it took 186.32 days on average for the stock forecasts to be realized with a an average price target met ratio 62.85

Which analyst has the current highest performing score on APLS (Apellis Pharmaceuticals) with a proven track record?

STEVEN SEEDHOUSE

Which analyst has the most public recommendations on APLS (Apellis Pharmaceuticals)?

Steven Seedhouse works at RAYMOND JAMES and has 7 price targets and 5 ratings on APLS

Which analyst is the currently most bullish on APLS (Apellis Pharmaceuticals)?

Madhu Kumar with highest potential upside - $121.53

Which analyst is the currently most reserved on APLS (Apellis Pharmaceuticals)?

Luca Issi with lowest potential downside - -$1.47

Apellis Pharmaceuticals in the News

High Growth Tech Stocks To Watch In The US July 2025

As the U.S. stock market navigates through a period of heightened volatility with the S&P 500 and Nasdaq Composite recently hitting record highs, investors are closely monitoring developments around tariffs and political shifts that could impact economic conditions. In this dynamic environment, identifying high-growth tech stocks requires careful consideration of their resilience to market fluctuations...

Apellis Pharmaceuticals' Funding Gaps, Weak Syfovre Sales Cloud Outlook, BofA Says

Apellis Pharmaceuticals (APLS) has had a difficult Q1 as charitable foundation funding gaps and weak PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?